A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)
Clinical trial NCT04351243 · COMPLETED
Trial details
- NCT number
- NCT04351243
- Sponsor
- Kinevant Sciences GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-15
- Primary completion
- 2020-12-01
- Enrollment
- 227
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.